entertainment -WSS

entertainment

author：entertainment 2025-09-27 09:38:18 - browse：7

A sign of pharmaceutical company Bayer in front of a blossomed tree — coverage from STAT — INA FASSBENDER/AFP via Getty Images

More hopeful news on the menopause front: Bayer announced on Monday encouraging results in two Phase 3 trials for its non-hormonal drug candidate, elinzanetant, meant to treat hot flashes. The results follow the recent market launch of Veozah, Astellas Pharma’s groundbreaking non-hormonal treatment for hot flashes, which was approved by the U.S. Food and Drug Administration last spring and received approval in the U.K., under the name Veozah, in December.

Elinzanetant is a neurokinin-1 and 3 receptor antagonist, and works by calming down the estrogen receptors in the brain that become hyperactive around menopause, causing hot flashes. The drug, a pill administered once a day, was shown to reduce both the frequency and intensity of hot flashes, and also met the secondary endpoints for improving sleep and quality of life, according to JoAnn Pinkerton, professor of obstetrics and gynecology and director of the Midlife Health at UVA Health, who is a clinical investigator for Bayer’s drug candidate.

Pinkerton said she was excited to see the broader quality of life improvements through elinzanetant: “Women have more than just hot flashes — it’s actually more about hot flushes, sweats, fatigue, lack of sleep and some of the mood changes that go on during [menopause].”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Psychedelics group wrestles with new pharma identity
Next article： Wegovy trial has doctors encouraged over new possibilities

hotspot

focus

WSS

A biotech analyst on neuroscience, placebo effect, not over

ACA's risk program benefits Blue Cross Blue Shield insurers

Biden declares emergency in flood

American woman, child freed after being kidnapped in Haiti last month

Judge agrees to delay next hearing in Trump classified documents case

Judge agrees to delay next hearing in Trump classified documents case

hotspot

entertainment

focus

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

Wegovy trial has doctors encouraged over new possibilities

After affirmative action ruling, medical educators look to 'holistic review'

Wegovy trial has doctors encouraged over new possibilities

As demand for Covid shots wanes, Moderna seeks its next success

How to use technology to prevent future drug shortages

Peter Hotez and the public health issue of online harassment

See Ryan Reynolds, Hugh Jackman suited up in 1st look at 'Deadpool 3': Photo

Guidelines to prevent youth baseball injuries need more muscle

‘Insidious 5’ topples 'Indiana Jones' before ‘Mission: Impossible’ launches

knowledge

Drastic changes should bring profitability, startup health insurers say

Jack Smith previously got search warrant for Trump's Twitter, new court docs show

US sending controversial cluster munitions to Ukraine until other ammo is ready: Kirby

What to know about Virgin Galactic's 1st mission taking paying customers to space

Dozens of beaches across Northeast closed for swimming due to high levels of bacteria in water

Eisai exec who led development of Alzheimer’s drug to retire

hotspot

hotspot

focus

Wikipedia